Roche J, Isacco L, Masurier J, Pereira B, Mougin F, Chaput J
Int J Obes (Lond). 2020; 44(4):753-770.
PMID: 31911659
DOI: 10.1038/s41366-019-0497-7.
Islam M, Alam M, Neogi P
World J Microbiol Biotechnol. 2014; 8(2):160-3.
PMID: 24425400
DOI: 10.1007/BF01195838.
Richardson S, Evans D, Feeley J
Infect Immun. 1970; 1(6):546-54.
PMID: 16557774
PMC: 415940.
DOI: 10.1128/iai.1.6.546-554.1970.
DiRita V, Engleberg N, Heath A, Miller A, Crawford J, Yu R
Philos Trans R Soc Lond B Biol Sci. 2000; 355(1397):657-65.
PMID: 10874738
PMC: 1692771.
DOI: 10.1098/rstb.2000.0606.
Lin Z, Kumagai K, Baba K, Mekalanos J, Nishibuchi M
J Bacteriol. 1993; 175(12):3844-55.
PMID: 8509337
PMC: 204801.
DOI: 10.1128/jb.175.12.3844-3855.1993.
Vibrio cholerae hlyB is a member of the chemotaxis receptor gene family.
Jeffery C, Koshland Jr D
Protein Sci. 1993; 2(9):1532-5.
PMID: 8401237
PMC: 2142450.
DOI: 10.1002/pro.5560020918.
Cholera.
Kaper J, Morris Jr J, Levine M
Clin Microbiol Rev. 1995; 8(1):48-86.
PMID: 7704895
PMC: 172849.
DOI: 10.1128/CMR.8.1.48.
Lincomycin increases synthetic rate and periplasmic pool size for cholera toxin.
Levner M, Urbano C, RUBIN B
J Bacteriol. 1980; 143(1):441-7.
PMID: 7400099
PMC: 294266.
DOI: 10.1128/jb.143.1.441-447.1980.
Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli.
Hirst T, Sanchez J, Kaper J, Hardy S, Holmgren J
Proc Natl Acad Sci U S A. 1984; 81(24):7752-6.
PMID: 6393126
PMC: 392230.
DOI: 10.1073/pnas.81.24.7752.
Fine structure of Vibrio cholerae during toxin production.
Kennedy J, Richardson S
J Bacteriol. 1969; 100(3):1393-401.
PMID: 5361220
PMC: 250350.
DOI: 10.1128/jb.100.3.1393-1401.1969.
Biochemistry of vibrio cholerae virulence. II. Skin permeability factor-cholera enterotoxin production in a chemically defined medium.
Callahan 3rd L, Ryder R, Richardson S
Infect Immun. 1971; 4(5):611-8.
PMID: 5170548
PMC: 416361.
DOI: 10.1128/iai.4.5.611-618.1971.
Biochemistry of Vibrio cholerae virulence. 3. Nutritional requirements for toxin production and the effects of pH on toxin elaboration in chemically defined media.
Callahan 3rd L, Richardson S
Infect Immun. 1973; 7(4):567-72.
PMID: 4762111
PMC: 422723.
DOI: 10.1128/iai.7.4.567-572.1973.
Selective destruction of skin permeability activity in cholera toxin: effect of acid on cholera enterotoxin.
Bhattacharjee A, Mosley W
Infect Immun. 1973; 8(2):133-6.
PMID: 4737674
PMC: 422823.
DOI: 10.1128/iai.8.2.133-136.1973.
Vibrio cholerae enterotoxin and its mode of action.
Pierce N, Greenough 3rd W, Carpenter Jr C
Bacteriol Rev. 1971; 35(1):1-13.
PMID: 4324714
PMC: 378369.
DOI: 10.1128/br.35.1.1-13.1971.
Studies on the chick-lethal toxin of Eecherichia coli.
Truscott R
Can J Comp Med. 1973; 37(4):375-81.
PMID: 4270809
PMC: 1319795.
Development of a purified cholera toxoid. I. Purification of toxin.
Rappaport R, RUBIN B, TINT H
Infect Immun. 1974; 9(2):294-303.
PMID: 4205945
PMC: 414801.
DOI: 10.1128/iai.9.2.294-303.1974.
In vitro and in vivo cholera toxin production by classical and El Tor isolates of Vibrio cholerae.
Turnbull P, Lee J, Miliotis M, Still C, Isaacson M, Ahmad Q
J Clin Microbiol. 1985; 21(6):884-90.
PMID: 4008618
PMC: 271811.
DOI: 10.1128/jcm.21.6.884-890.1985.
Large production of cholera toxin by Vibrio cholerae O1 in yeast extract peptone water.
Iwanaga M, Kuyyakanond T
J Clin Microbiol. 1987; 25(12):2314-6.
PMID: 3429623
PMC: 269478.
DOI: 10.1128/jcm.25.12.2314-2316.1987.
New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor.
Iwanaga M, Yamamoto K
J Clin Microbiol. 1985; 22(3):405-8.
PMID: 2995438
PMC: 268420.
DOI: 10.1128/jcm.22.3.405-408.1985.
Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture.
Jonson G, Svennerholm A, Holmgren J
Infect Immun. 1989; 57(6):1809-15.
PMID: 2722240
PMC: 313360.
DOI: 10.1128/iai.57.6.1809-1815.1989.